Moreover, miR-125b-5p can negatively regulate hepatitis C virus (HCV) infection via targeting Human antigen R (HuR) as an affirmative regulator of HCV replication in both liver carcinoma cells and serum of HCV-infected patients [182]. Here, ELAVL1 is linked to hepatocellular carcinoma.